Brzeczko Albert W 4
4 · ACURA PHARMACEUTICALS, INC · Filed Nov 20, 2023
Insider Transaction Report
Form 4
Brzeczko Albert W
VP Technical Affairs
Transactions
- Exercise/Conversion
Restricted Stock Unit (2021 Plan)
2023-11-20+40,000→ 0 totalExercise: $0.01→ Common Stock (40,000 underlying) - Exercise/Conversion
Common Stock
2023-11-20+40,000→ 486,001 total
Footnotes (4)
- [F1]Represents exchange of restricted stock units.
- [F2]Par value of $.01 must be paid by Reporting Person upon exchange of Restricted Stock Units for stock.
- [F3]Not Applicable.
- [F4]40,000 Restricted Stock Units were granted on March 16, 2022 and were 100% vested on December 31, 2022